Russell Investments Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.6K | Buy |
+20,556
| New | +$42.6K | ﹤0.01% | 3019 |
|
|
2024
Q4 | – | Sell |
-307
| Closed | -$611 | – | 3743 |
|
|
2024
Q3 | $611 | Sell |
307
-20
| -6% | -$40 | ﹤0.01% | 3545 |
|
|
2024
Q2 | $1.15K | Buy |
+327
| New | +$1.15K | ﹤0.01% | 3417 |
|
|
2023
Q4 | – | Sell |
-200
| Closed | -$206 | – | 3247 |
|
|
2023
Q3 | $206 | Buy |
+200
| New | +$206 | ﹤0.01% | 3493 |
|
|
2022
Q1 | – | Sell |
-4,302
| Closed | -$39K | – | 2829 |
|
|
2021
Q4 | $39K | Buy |
+4,302
| New | +$39K | ﹤0.01% | 2917 |
|
|
2021
Q3 | – | Sell |
-129,458
| Closed | -$2.01M | – | 3115 |
|
|
2021
Q2 | $2.01M | Sell |
129,458
-54,283
| -30% | -$842K | ﹤0.01% | 1920 |
|
|
2021
Q1 | $2.98M | Buy |
183,741
+5,265
| +3% | +$85.3K | 0.01% | 1647 |
|
|
2020
Q4 | $3.78M | Buy |
178,476
+64,284
| +56% | +$1.36M | 0.01% | 1397 |
|
|
2020
Q3 | $1.69M | Sell |
114,192
-8,303
| -7% | -$123K | ﹤0.01% | 1791 |
|
|
2020
Q2 | $1.8M | Buy |
122,495
+28,701
| +31% | +$422K | ﹤0.01% | 1698 |
|
|
2020
Q1 | $1.1M | Sell |
93,794
-11,333
| -11% | -$133K | ﹤0.01% | 1794 |
|
|
2019
Q4 | $2.47M | Buy |
105,127
+40,797
| +63% | +$959K | ﹤0.01% | 1613 |
|
|
2019
Q3 | $1.19M | Buy |
64,330
+19,342
| +43% | +$359K | ﹤0.01% | 1925 |
|
|
2019
Q2 | $836K | Hold |
44,988
| – | – | ﹤0.01% | 2059 |
|
|
2019
Q1 | $1.1M | Buy |
44,988
+3,337
| +8% | +$81.5K | ﹤0.01% | 2014 |
|
|
2018
Q4 | $1.08M | Sell |
41,651
-7,645
| -16% | -$198K | ﹤0.01% | 1907 |
|
|
2018
Q3 | $1.56M | Sell |
49,296
-1,600
| -3% | -$50.6K | ﹤0.01% | 1877 |
|
|
2018
Q2 | $1.98M | Buy |
50,896
+1,116
| +2% | +$43.4K | ﹤0.01% | 1761 |
|
|
2018
Q1 | $1.37M | Buy |
+49,780
| New | +$1.37M | ﹤0.01% | 2048 |
|
|
2017
Q2 | – | Sell |
-35,506
| Closed | -$532K | – | 2989 |
|
|
2017
Q1 | $532K | Buy |
+35,506
| New | +$532K | ﹤0.01% | 2402 |
|